Prescription Opioid Use and Satisfaction With Care Among Adults With Musculoskeletal Conditions – free full-text /PMC5758314/ – Jan/Feb 2018
PURPOSE: In the current payment paradigm, reimbursement is partially based on patient satisfaction scores. We sought to understand the relationship between prescription opioid use and satisfaction with care among adults who have musculoskeletal conditions.
METHODS: We performed a cross-sectional study using nationally representative data from the 2008–2014 Medical Expenditure Panel Survey.
This is the kind of nonsense that passes as scientific opioid research these days. It’s no wonder that there’s so much confusion when such context-free studies look only at the dose of a medication without any regard for its medicinal purpose.
We assessed whether prescription opioid use is associated with satisfaction with care among US adults who had musculoskeletal conditions.
Specifically, using 5 key domains of satisfaction with care, we examined the association between opioid use (overall and according to the number of prescriptions received) and high satisfaction, defined as being in the top quartile of overall satisfaction ratings.
RESULTS: Among 19,566 adults with musculoskeletal conditions, we identified 2,564 (13.1%) who were opioid users, defined as receiving 1 or more prescriptions in 2 six-month time periods.
In analyses adjusted for sociodemographic characteristics and health status, compared with nonusers, opioid users were more likely to report high satisfaction with care (odds ratio = 1.32; 95% CI, 1.18–1.49).
According to the level of use, a stronger association was noted with moderate opioid use (odds ratio = 1.55) and heavy opioid use (odds ratio = 1.43) (P <.001 for trend).
CONCLUSIONS Among patients with musculoskeletal conditions, those using prescription opioids are more likely to be highly satisfied with their care.
Considering that emerging reimbursement models include patient satisfaction, future work is warranted to better understand this relationship.
The ignorance exposed here truly amazes me.
The primary motivation for people see doctors in the first place is to get relief from some pain, either by cure or by symptom palliation, and their satisfaction is thus dependent on how effectively their pain is treated.
If patients cannot be “cured”, then the doctor is obliged to find some other way to relieve their pain. When alternate treatments are unsuccessful and only opioids are effective for them, patients will not be satisfied if they are forbidden the only relief available to them.
Where’s the mystery? How could anyone expect anything different?
Patients who aren’t “cured” and are also left in pain will obviously be unhappy because their health issue has not been solved or effectively treated. Such “non-treatment” would not be tolerated in any other medical field.
- We can’t cure your diabetes, but we won’t give you insulin because “it’s too dangerous” (abuse of this medication by taking extreme doses can lead to hypoglycemic shock and subsequent death).
- We can’t cure your high blood pressure, but we won’t give you antihypertensive medication because “it’s bad for you” (abuse of this medication can lead to an extreme drop in blood pressure, whereupon the patient could lose consciousness and fall/crash/die.)
The extent to which prescription opioid use is associated with patient satisfaction is currently unknown.
he rise in the prescription of opioids was presumably initially driven by a desire to improve the well-being of patients having pain.
If, in fact, prescription opioid use is associated with higher patient satisfaction with care, such payment incentives may be perpetuating the prescribing of these medications.
Alternatively, if prescription opioid use is not associated with patient satisfaction, these medications may have less of an effect than anticipated. It is important for policymakers, clinicians, and other stakeholders to have an accurate understanding of the potential drivers of prescribing in order to develop strategies designed to mitigate the serious public health risks.
We therefore analyzed data from the Medical Expenditure Panel Survey (MEPS) to evaluate whether prescription opioid use is associated with higher levels of patient satisfaction among a large sample of US adults having musculoskeletal conditions.
This is like evaluating any other medication without having the slightest idea of what it treats. I cannot understand how anyone finds this kind of pointless, context-free, reason-free evaluation to be valid and have any meaning for anything at all.
It’s like evaluating winter coats or bathing suits during any season without taking into account the temperature. No one would dare suggest such a ridiculous study because the absurdities are so obvious… unless it’s opioid medication being evaluated.
The full text of this study is available, but I’m not going to bother looking any farther because the craziness only repeats itself.